The modest 6% revenue growth and lack of earnings data suggest no immediate catalyst. Monitor Q1 FY27 sales for sustained momentum, particularly in Canada where Q4 showed a strong rebound. The company's small $8M market cap means even modest revenue beats can move the stock, but the current update is routine.
Price Chart
Executive Summary
Immuron reported FY26 global sales of AUD$7.7M, up 6% year-over-year, driven by 10% growth in Australia and 7% in the US (13% in USD). Canadian sales fell 55% for the full year but rebounded sharply in Q4 (+376% vs prior year). The unaudited sales update shows steady but modest growth for Travelan, with no earnings or guidance provided.
Key Facts
- Global FY26 sales AUD$7.7M, up 6% on prior comparative period (pcp)
- Australia FY26 sales AUD$5.8M, up 10% on pcp
- USA FY26 sales AUD$1.8M (USD$1.2M), up 7% in AUD and 13% in USD
- Canada FY26 sales AUD$0.2M, down 55% on pcp, but Q4 FY26 sales up 376% on pcp
- Fourth consecutive quarter of year-over-year sales growth
- No earnings, profitability, or forward guidance provided
Financial Impact
FY26 global revenue of AUD$7.7M (~USD$5.2M) with 6% YoY growth; no impact on profitability disclosed
Risk Factors
- Canadian sales declined 55% for the full year despite Q4 rebound
- Currency headwinds from AUD strengthening against USD
- No profitability or cash flow data provided; reliance on Travelan as sole revenue driver
- Small market cap ($8M) increases volatility risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-078468 |
| Document: ea0298206-6k_immuron.htm | 0001213900-26-078468 |
| Document: 0001213900-26-078468-index-headers.html | 0001213900-26-078468 |
| Document: 0001213900-26-078468-index.html | 0001213900-26-078468 |
| Document: 0001213900-26-078468.txt | 0001213900-26-078468 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 6-K | $0.9320 | awaiting T+60 | — | $0.9200 (−1.29%) |
Oct 23, 2026 3d ago | 424B5 | $0.9320 | awaiting T+60 | — | $0.9200 (−1.29%) |
Oct 21, 2026 5d ago | 6-K | $0.9490 | awaiting T+60 | — | $0.9200 (−3.06%) |
Oct 16, 2026 10d ago | 6-K | $0.9821 | awaiting T+60 | — | $0.9200 (−6.32%) |
Oct 13, 2026 13d ago | 6-K | $1.04 | awaiting T+60 | — | $0.9200 (−11.54%) |
Sep 24, 2026 4w ago | 20-F | $1.19 | awaiting T+60 | — | $0.9200 (−22.69%) |
Sep 24, 2026 4w ago | 6-K | $1.19 | awaiting T+60 | — | $0.9200 (−22.69%) |
Sep 21, 2026 5w ago | 6-K | $1.26 | awaiting T+60 | — | $0.9200 (−26.69%) |
Sep 4, 2026 7w ago | Press Release | $1.80 | awaiting T+60 | — | $0.9200 (−48.89%) |
Aug 28, 2026 8w ago | 6-K | $1.15 | awaiting T+60 | — | $0.9200 (−20.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers